title: Kinetic study on the reaction of cisplatin with metallothionein.
abstract: The binding of cisplatin to metallothionein (MT) was investigated at 37 degrees C in 10 mM Tris-NO3 (pH approximately 7.4) and 4.62 mM NaCl. The conditions were chosen to mimic passage of clinical concentrations of cisplatin through the cytosol. The reactions were monitored by high-performance liquid chromatography (HPLC), atomic absorption spectroscopy, and ultraviolet (UV) absorption spectroscopy. The UV data showed that several reactions occur, the first of which does not affect the absorbance (no Pt-sulfur bond formation). They also suggested that if [cisplatin] is large compared with [MT], the rate of subsequent reaction is between first and second order in [cisplatin] and between zeroth and first order in [MT]. HPLC eluates with 24 < retention time (tR) < 27 min contained undialyzable Pt, which increased with reaction time and corresponded to Pt-thionein product. Eluates with 3 < tR < 7 min corresponded to unbound cisplatin and allowed determination of second-order rate constants (k), using the second-order rate equation. The k value for cisplatin reacting with apo-MT was approximately 0.14 M-1 s-1, Cd/Zn-MT approximately 0.75 M-1 s-1, Cd7-MT approximately 0.53 M-1 s-1, and Zn7-MT approximately 0.65 M-1 s-1. Thus, cisplatin displaced Cd and Zn equally well. Leukocyte MT concentration was approximately 1.0 mM, so that the kinetics of cisplatin binding to cellular MT is pseudo-first order (pseudo-first-order rate constant, approximately 0.63 x 10-3 s-1; half-life, approximately 18 min). With [cisplatin] = 10 microM, the rate of cisplatin reaction with MT is approximately 6.3 micromol s-1 cm-3. We conclude that cellular MT can trap significant amounts of cisplatin and may efficiently contribute to cisplatin resistance.
authors.affiliation: State University of New York, Upstate Medical University, Department of Pediatrics, 750 East Adams Street, Syracuse, NY 13210, USA.
authors.forename: Douglas
authors.initials: D
authors.lastname: Hagrman
authors.forename: Jerry
authors.initials: J
authors.lastname: Goodisman
authors.forename: James C
authors.initials: JC
authors.lastname: Dabrowiak
authors.forename: Abdul-Kader
authors.initials: AK
authors.lastname: Souid
mesh_terms: D000818:Animals; D002104:Cadmium / Q000097:blood; D002851:Chromatography, High Pressure Liquid; D002945:Cisplatin / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics*; D003600:Cytosol / Q000201:enzymology; D004351:Drug Resistance / Q000502:physiology; D004880:Ergothioneine / Q000737:chemistry; D006801:Humans; D007700:Kinetics; D007962:Leukocytes / Q000737:chemistry / Q000378:metabolism; D008668:Metallothionein / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics* / Q000502:physiology; D010984:Platinum / Q000097:blood; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D013054:Spectrophotometry, Atomic; D013056:Spectrophotometry, Ultraviolet; D015032:Zinc / Q000097:blood
chemical_list: D002104:Cadmium; D010984:Platinum; D008668:Metallothionein; D004880:Ergothioneine; D015032:Zinc; D002945:Cisplatin